Tag: <span>Mesothelioma News</span>

Oklahoma Governor Signs Asbestos Clean-Up Bill

Oklahoma Governor Mary Fallin signs an asbestos bill into law to reduce regulatory burden of asbestos abatement.

Penn Medicine: Immunotherapy drug pembrolizumab shows promise for mesothelioma patients

The PD-1 inhibitor pembrolizumab, a cancer immunotherapy drug, shrank or halted growth of tumors in 76 percent of patients with pleural mesothelioma , a rare and deadly form of cancer that arises in the outer lining of the lungs and internal chest wall…

Penn Medicine: Immunotherapy drug pembrolizumab shows promise for mesothelioma patients

The PD-1 inhibitor pembrolizumab, a cancer immunotherapy drug, shrank or halted growth of tumors in 76 percent of patients with pleural mesothelioma , a rare and deadly form of cancer that arises in the outer lining of the lungs and internal chest wall…

Investigational personalized cellular therapy tolerated well by patients

Genetically modified versions of patients’ own immune cells successfully traveled to tumors they were designed to attack in an early-stage trial for mesothelioma and pancreatic and ovarian cancers at the Perelman School of Medicine at the University of…

Investigational personalized cellular therapy tolerated well by patients

Promising results of Phase I trial show successful migration of immune cells to tumor sitesGenetically modified versions of patients’ own immune cells successfully traveled to tumors they were…

Penn Medicine: Immunotherapy drug pembrolizumab shows promise for mesothelioma patients

PD-1 inhibitor is safe, shrank tumors or stabilized disease in most patientsThe PD-1 inhibitor pembrolizumab, a cancer immunotherapy drug, shrank or halted growth of tumors in 76 percent of…

Penn Medicine: Immunotherapy drug pembrolizumab shows promise for mesothelioma patients

PD-1 inhibitor is safe, shrank tumors or stabilized disease in most patientsThe PD-1 inhibitor pembrolizumab, a cancer immunotherapy drug, shrank or halted growth of tumors in 76 percent of…

Investigational personalized cellular therapy tolerated well by patients

Promising results of Phase I trial show successful migration of immune cells to tumor sitesGenetically modified versions of patients’ own immune cells successfully traveled to tumors they were…

Australian Capital Territory Government Buys Back Asbestos-Ridden Homes Without Secured Loan

The Australian Capital Territory bought back 19 “Mr. Fluffy” asbestos-ridden homes before the ACT and Commonwealth $1 billion loan was signed.

Australian Capital Territory Government Buys Back Asbestos-Ridden Homes Without Secured Loan

The Australian Capital Territory bought back 19 “Mr. Fluffy” asbestos-ridden homes before the ACT and Commonwealth $1 billion loan was signed.